🇺🇸 Discontinuation of imipenem-cilastatin or meropenem in United States

Discontinuation of imipenem-cilastatin or meropenem (Discontinuation of imipenem-cilastatin or meropenem) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Discontinuation of imipenem-cilastatin or meropenem in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Discontinuation of imipenem-cilastatin or meropenem approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Discontinuation of imipenem-cilastatin or meropenem in United States?

Amsterdam UMC, location VUmc is the originator. The local marketing authorisation holder may differ — check the official source linked above.